🔎 Trials Near Me

Home › Suicide › NCT07383714

Nudging Parental Actions for Youth Suicide Prevention

Recruiting

Nudging Parental Action With A Randomized Controlled Trial of Text Messaging Intervention for Suicide Prevention

Who can join

Ages 13 to 17 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Guardian must be able and willing to provide informed consent, and the participant must be able and willing to provide assent.
* Parent and adolescent willingness and ability to participate in study procedures and complete assessments at baseline, 6 weeks, and 12 weeks.
* Presentation to the ED for a suicide-related emergency, defined as suicidal ideation within the last 2 weeks or a suicide attempt within the past month.
* Adolescents aged 12-17 years during the consent.
* Access to a mobile phone with text messaging capability for the parent/legal guardian.
* Ability to communicate in English.

Exclusion Criteria:

* Absence of a legal guardian capable of providing consent.
* Parents/legal guardians without access to a mobile phone with texting capability.
* Inability to communicate in English.
* Adolescents in state custody or under legal restrictions that prevent study participation.
* Adolescents involved in the justice system in a manner that would interfere with study participation.
* Adolescents with autism spectrum disorder or intellectual development disorder needing substantial or very substantial support

About the study

The goal of the study is to determine effectiveness of a behaviorally informed text messaging intervention to help parents increase safety practices and reduce their teens' access to lethal means following a suicide-related emergency department visit.

What is being tested

Sponsor: University of Texas Southwestern Medical Center · Participants: 129 · Started: Jun 10, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07383714

Locations in the U.S.

TexasChildren's Medical Center, Dallas

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.